Commercializing biotechnology in China
I recently had the opportunity to conduct a brief interview with Mireille Gingras, Ph.D. President and CEO of HUYA Bioscience […]
General Biotechnology, Guest content
General Biotechnology, Guest content
Contract research helps keep drug pipeline flowing
Guest content from Turner Investment Partners‘ Heather Flick McMeekin, Frank Sustersic, Vijay Shankaran, and Theresa Hoang: Contract research helps keep
Contract research helps keep drug pipeline flowing Read Post »
Biotechnology Book Reviews, General Biotechnology, Talks and Publications
Building Biotechnology 3rd Edition now available
Building Biotechnology: Business, Regulations, Patents, Law, Politics, Science 460 pages Hardcover: 978-09734676-5-9 Softcover: 978-09734676-6-6 Third Edition August, 2008 Homepage The
Building Biotechnology 3rd Edition now available Read Post »
General Biotechnology, Talks and Publications
Beyond the Business Plan: Managing unexpected risk in biotechnology business development
Here’s a slideshow of a talk I recently gave at the Johns Hopkins biotechnology MS/MBA program. The purpose is to
Beyond the Business Plan: Managing unexpected risk in biotechnology business development Read Post »
General Biotechnology
Roche and Genentech's mating dance — This isn't the first time
Roche has floated an offer to acquire Genentech, a move which has raised a flurry of questions about the sustainability
Roche and Genentech's mating dance — This isn't the first time Read Post »
General Biotechnology
Roche and Genentech’s mating dance — This isn’t the first time
Roche has floated an offer to acquire Genentech, a move which has raised a flurry of questions about the sustainability
Roche and Genentech’s mating dance — This isn’t the first time Read Post »
General Biotechnology, Guest content
Background: The Clinical and Translational Science Awards Consortium (CTSA program)
Guest content from Christopher Starr: After years of confusion and neglect, translational research is now becoming institutionalized. Citing the barriers
Background: The Clinical and Translational Science Awards Consortium (CTSA program) Read Post »
General Biotechnology, Guest content
Why the market does not like Flurizan
Guest content from Nicolaj H. Nielsen, managing director of Biostrat. A case-study on the recent licensing-deal between Myriad and Lundbeck:
Uncategorized
Advertise on Biotechblog
Reach a targeted audience with BiotechBlog. Advertising opportunities are available on BiotechBlog. BiotechBlog is syndicated by BlogBurst, which means that
General Biotechnology
Journal of Commercial Biotechnology — July 2008
The March 2008 issue of the Journal of Commercial Biotechnology is now available. This issue focuses on biotechnology marketing and
